Literature DB >> 17909265

Rho GDP dissociation inhibitor alpha interacts with estrogen receptor alpha and influences estrogen responsiveness.

Saad El Marzouk1, Jennifer R Schultz-Norton, Varsha S Likhite, Ian X McLeod, John R Yates, Ann M Nardulli.   

Abstract

Estrogen receptor alpha (ER alpha) is a ligand-activated transcription factor that regulates expression of estrogen-responsive genes. Upon binding of the ligand-occupied ER alpha to estrogen response elements (EREs) in DNA, the receptor interacts with a variety of coregulatory proteins to modulate transcription of target genes. We have isolated and identified a number of proteins associated with the DNA-bound ER alpha. One of these proteins, Rho guanosine diphosphate (GDP) dissociation inhibitor alpha (RhoGDI alpha), is a negative regulator of the Rho family of GTP-binding proteins. In this study, we demonstrate that endogenously expressed RhoGDI alpha is present in the nucleus as well as the cytoplasm of MCF-7 breast cancer cells, and that RhoGDI alpha binds directly to ER alpha, alters the ER alpha-ERE interaction, and influences the ability of ER alpha to regulate transcription of a heterologous estrogen-responsive reporter plasmid in transient transfection assays as well as endogenous, estrogen-responsive genes in MCF-7 cells. Our studies suggest that, in addition to the activity of RhoGDI alpha in the cytoplasm, it also influences ER alpha signaling in the nucleus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17909265     DOI: 10.1677/JME-07-0055

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  19 in total

Review 1.  Rho, nuclear actin, and actin-binding proteins in the regulation of transcription and gene expression.

Authors:  Eeva Kaisa Rajakylä; Maria K Vartiainen
Journal:  Small GTPases       Date:  2014-03-06

2.  Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α.

Authors:  Ines Barone; Lauren Brusco; Guowei Gu; Jennifer Selever; Amanda Beyer; Kyle R Covington; Anna Tsimelzon; Tao Wang; Susan G Hilsenbeck; Gary C Chamness; Sebastiano Andò; Suzanne A W Fuqua
Journal:  J Natl Cancer Inst       Date:  2011-03-29       Impact factor: 13.506

Review 3.  Pleiotropic functions of Rho GTPase signaling: a Trojan horse or Achilles' heel for breast cancer treatment?

Authors:  P R McHenry; T Vargo-Gogola
Journal:  Curr Drug Targets       Date:  2010-09       Impact factor: 3.465

4.  RhoA and RhoC differentially modulate estrogen receptor α recruitment, transcriptional activities, and expression in breast cancer cells (MCF-7).

Authors:  Emilie Malissein; Elise Meunier; Isabelle Lajoie-Mazenc; Claire Médale-Giamarchi; Florence Dalenc; Sophie F Doisneau-Sixou
Journal:  J Cancer Res Clin Oncol       Date:  2013-10-06       Impact factor: 4.553

5.  Long-range transcriptional control of progesterone receptor gene expression.

Authors:  Jamie Bonéy-Montoya; Yvonne S Ziegler; Carol D Curtis; Jonathan A Montoya; Ann M Nardulli
Journal:  Mol Endocrinol       Date:  2009-12-01

6.  Isolation of proteins associated with the DNA-bound estrogen receptor alpha.

Authors:  Jennifer R Schultz-Norton; Yvonne S Ziegler; Varsha S Likhite; Ann M Nardulli
Journal:  Methods Mol Biol       Date:  2009

7.  ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling.

Authors:  Heon Yung Gee; Pawaree Saisawat; Shazia Ashraf; Toby W Hurd; Virginia Vega-Warner; Humphrey Fang; Bodo B Beck; Olivier Gribouval; Weibin Zhou; Katrina A Diaz; Sivakumar Natarajan; Roger C Wiggins; Svjetlana Lovric; Gil Chernin; Dominik S Schoeb; Bugsu Ovunc; Yaacov Frishberg; Neveen A Soliman; Hanan M Fathy; Heike Goebel; Julia Hoefele; Lutz T Weber; Jeffrey W Innis; Christian Faul; Zhe Han; Joseph Washburn; Corinne Antignac; Shawn Levy; Edgar A Otto; Friedhelm Hildebrandt
Journal:  J Clin Invest       Date:  2013-07-08       Impact factor: 14.808

8.  The role of retinoblastoma-associated proteins 46 and 48 in estrogen receptor alpha mediated gene expression.

Authors:  Amy L Creekmore; Kjirsten A Walt; Jennifer R Schultz-Norton; Yvonne S Ziegler; Ian X McLeod; John R Yates; Ann M Nardulli
Journal:  Mol Cell Endocrinol       Date:  2008-06-05       Impact factor: 4.102

9.  RhoGDIα downregulates androgen receptor signaling in prostate cancer cells.

Authors:  Yezi Zhu; Chengfei Liu; Ramakumar Tummala; Nagalakshmi Nadiminty; Wei Lou; Allen C Gao
Journal:  Prostate       Date:  2013-08-06       Impact factor: 4.104

10.  Using RNA interference to study protein function.

Authors:  Carol D Curtis; Ann M Nardulli
Journal:  Methods Mol Biol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.